The bill, known as the "Emerson Kate Cole Act," amends existing school medication policies to enhance the management of allergies and asthma in students. It requires school districts to adopt policies that mandate the administration of Epinephrine and inhalers by trained school employees in cases of anaphylactic reactions or respiratory distress. Specifically, if Epinephrine is administered, the school must call 911 and notify the student's parent or guardian of any possible allergic reaction. Additionally, the bill stipulates that school districts must utilize model policies developed by the State Board of Education and the State Board of Health, which will include annual training for teachers and school employees on recognizing anaphylaxis and administering Epinephrine.

The legislation also emphasizes the importance of parental involvement, requiring written authorization for self-administration of medications and waivers of liability. It establishes that school districts shall incur no liability for injuries resulting from the administration of these medications, provided that proper protocols are followed. The act is set to take effect on July 1, 2025, and includes provisions for emergency implementation to ensure the immediate safety and health of students.